文献速递头颈神经MR

眼眶MRI突眼度测量的可靠性:多中心前瞻性研究

Reliability of Orbital MRI-Based Proptosis Measurement: A Multicenter Prospective Study.
PubMed 文献 · Acad Radiol · 2026-07-23

本研究回顾性分析250例甲状腺相关眼病患者,评估基于MRI的突眼度测量与自动测量工具的可重复性。结果显示MRI测量观察者间一致性高(ICC 0.948–0.954),与Hertel突眼计相关性为ρ=0.76–0.80,自动工具外部验证CCC达0.928–0.973。

要点

  • MRI突眼测量观察者间一致性极佳,2D与3D序列ICC均高于0.94,可用于多医师报告。
  • 自动测量工具跨中心验证CCC为0.928–0.973,可用于纵向精确监测突眼变化。
  • 当Hertel突眼计测量结果不一致或需高精度随访时,MRI测量是可靠的补充手段。

核心结论

  • 基于MRI的自动突眼测量工具提供标准化、可重复的测量方案,可作为Hertel突眼计的补充,尤其适用于临床测量不一致或需纵向精确监测的病例。

研究设计与样本

  • 多中心研究,回顾性分析中心一前瞻性收集的250例甲状腺相关眼病患者,并由三位放射科医师独立完成2D与3D MRI突眼测量。
  • 临床Hertel突眼计测量在MRI检查一周内完成作为对照,自动工具以高年资放射科医师的手动标注为金标准进行内部验证。
  • 自动工具外部验证使用中心二(n=65)与中心三(n=48)的轴位2D MRI数据,评估跨中心泛化能力。

关键影像表现/征象

  • 三位医师基于眼眶MRI的突眼度测量在2D序列上ICC为0.948(95% CI:0.938–0.957),在3D序列上ICC为0.954(95% CI:0.939–0.966)。

诊断标准与关键数值

  • 2D MRI序列观察者间一致性:ICC为0.948,95% CI为0.938–0.957。
  • 3D MRI序列观察者间一致性:ICC为0.954,95% CI为0.939–0.966。
  • MRI测量与Hertel突眼计的Spearman相关系数ρ为0.76–0.80。
  • 自动工具验证集一致性相关系数CCC为0.928–0.973,组内相关系数ICC为0.916–0.973。

临床应用与阅片要点

  • 报告甲状腺相关眼病突眼度时可采用MRI轴位2D或3D序列进行测量,不同医师间结果一致性高,适合多学科协作。
  • 对需要纵向监测突眼变化的患者,MRI自动测量工具可减少人工测量变异,提高随访精度。
  • Hertel突眼计测量受操作者影响较大,当两次测量不一致或临床怀疑误差时应加做MRI突眼测量。

局限性

  • 研究为回顾性设计,中心一患者虽为前瞻性入组,但影像与临床数据的分析为回顾性完成。
  • 自动工具的标注金标准依赖单一高年资放射科医师的手动标注,未涉及多位专家共识。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Accurate proptosis measurement change is critical for managing thyroid-associated ophthalmopathy (TAO), yet traditional Hertel exophthalmometry suffers from inter-observer inconsistency. This study aimed to investigate the efficacy of magnetic resonance imaging (MRI)-based proptosis measurement and developed an automated tool to enhance diagnostic reproducibility.

MATERIALS AND METHODS: We retrospectively analyzed data from 250 patients with TAO prospectively enrolled at Center 1 between December 2023 and June 2025. Proptosis was independently measured by three radiologists (R1-R3) using both 2D and 3D MRI sequences; clinical measurements via Hertel exophthalmometry were obtained within one week for comparison. An automated measurement tool was developed and internally validated using manual annotations from the senior radiologist (R1) as the ground truth. To assess generalizability, the tool was externally validated on axial 2D MRI datasets from two independent cohorts: Center 2 (n = 65) and Center 3 (n = 48).

RESULTS: Orbital MRI-based measurements demonstrated excellent inter-observer agreement for both 2D (ICC: 0.948; 95% CI: 0.938-0.957) and 3D sequences (ICC: 0.954; 95% CI: 0.939-0.966). MRI findings showed a strong correlation with Hertel exophthalmometry (Spearman's ρ = 0.76-0.80). The automated tool maintained high performance across all cohorts, achieving concordance correlation coefficients (CCC) of 0.928-0.973 and intraclass correlation coefficients (ICC) of 0.916-0.973 in validation.

CONCLUSION: This MRI-based automated tool provides a reliable, complementary, and standardized alternative to Hertel exophthalmometry, particularly useful when clinical measurements are discordant or demand high precision for longitudinal monitoring. It demonstrated excellent accuracy, efficiency, and cross-center generalizability.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Gou, Wu, Huang, et al. Reliability of Orbital MRI-Based Proptosis Measurement: A Multicenter Prospective Study. Acad Radiol. 2026. PMID: 42493352. doi:10.1016/j.acra.2026.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。